Fennec Pharmaceuticals Inc.
FENC · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $44.6M | $47.5M | −6.1% |
| Operating income | −$6.28M | $2.57M | |
| Net income | −$9.74M | −$440K | −2,114% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 12, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $19.6M | $12.5M | +56.8% |
| Operating income | $4.70M | −$200K | |
| Net income | $4.60M | −$600K |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Fennec's revenue in FY2025?
- $44.6M in FY2025 (Fiscal year ended Dec 31, 2025), −6.1% vs $47.5M a year earlier, per its 10-K filed Mar 2026.
- Was Fennec profitable in FY2025?
- No: net income was −$9.74M and operating income −$6.28M in FY2025.
- What was Fennec's revenue in Q3 2026?
- $19.6M (+56.8% vs a year earlier), per its Form 10-Q filed Nov 12, 2026.